Acute delirium as an initial manifestation of COVID-19 patients with acute ischemic stroke: Report on two cases

Psychiatric consequences and issues of long COVID on patients with prior psychiatric comorbidities: a scoping review

“…The effects of treatments were not discussed in the articles selected for the review, but Mazza et al ( 27 ) published an article on the effectiveness of SSRI in post-COVID depression, showing a quicker and better medical response to standard pharmacological treatment compared to non-COVID depression, even in groups of patients with a psychiatric history. The treatment should not be overlooked, as research shows that the rate of depression and anxiety, for instance, has a tendency to slightly increase with time, even in patients without psychiatric history, and therefore not to have a positive spontaneous evolution ( 28 ).…”

Psychiatric abnormalities in COVID-19 patients should prompt work-up for neuro-COVID

“…A psychiatric morbidity not discussed in this review is delirium ( Dehghani et al, 2022 ). Delirium has been reported as the initial manifestation of SARS-CoV-2 associated ischemic stroke ( Huang et al, 2022 ). Two patients, an 82yo male (case-1) and an 84yo male (case-2), were diagnosed with ischemic stroke after acute delirium had developed for seven days (case-1) and 13 days (case-2) respectively after the onset of mild SARS-CoV-2 infection ( Huang et al, 2022 ).…”

“…Delirium has been reported as the initial manifestation of SARS-CoV-2 associated ischemic stroke ( Huang et al, 2022 ). Two patients, an 82yo male (case-1) and an 84yo male (case-2), were diagnosed with ischemic stroke after acute delirium had developed for seven days (case-1) and 13 days (case-2) respectively after the onset of mild SARS-CoV-2 infection ( Huang et al, 2022 ). COVID-19 was treated with tocilizumab, dexamethasone, ceftriaxone, and remdesivir (case-1) respectively tocilizumab, dexamethasone, ceftriaxone, levofloxacin, and remdesivir (case-2) ( Huang et al, 2022 ).…”

“…Two patients, an 82yo male (case-1) and an 84yo male (case-2), were diagnosed with ischemic stroke after acute delirium had developed for seven days (case-1) and 13 days (case-2) respectively after the onset of mild SARS-CoV-2 infection ( Huang et al, 2022 ). COVID-19 was treated with tocilizumab, dexamethasone, ceftriaxone, and remdesivir (case-1) respectively tocilizumab, dexamethasone, ceftriaxone, levofloxacin, and remdesivir (case-2) ( Huang et al, 2022 ). In case-1 and case-2, middle cerebral artery (MCAD) ischemic stroke was diagnosed and treated appropriately, resulting in a favourable outcome.…”